Literature DB >> 8567973

The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.

R L Prigeon1, M E Røder, D Porte, S E Kahn.   

Abstract

Administration of exogenous insulin during an intravenous glucose tolerance test allows the use of the minimal model technique to determine the insulin sensitivity index in subjects with reduced endogenous insulin responses. To study the effect of different insulin administration protocols, we performed three intravenous glucose tolerance tests in each of seven obese subjects (age, 20-41 yr; body mass index, 30-43 kg/m2). Three different insulin administration protocols were used: a low-dose (0.025 U/kg) infusion given over 10 min, a low-dose (0.025 U/kg) bolus injection, and a high-dose (0.050 U/kg) bolus injection, resulting in peak insulin concentrations of 1,167 +/- 156, 3,014 +/- 483, and 6,596 +/- 547 pM, respectively. The mean insulin sensitivity index was 4.80 +/- 0.95 x 10(-5), 3.56 +/- 0.53 x 10(-5), and 2.42 +/- 0.40 x 10(-5) min-1/pM respectively (chi +/- SEM; P = 0.01). The association of higher peak insulin concentrations with lower measured insulin sensitivity values suggested the presence of a saturable process. Because results were not consistent with the known saturation characteristics of insulin action on tissue, a second saturable site involving the transport of insulin from plasma to interstitium was introduced, leading to a calculated Km of 807 +/- 165 pM for this site, a value near the 1/Kd of the insulin receptor. Thus, the kinetics of insulin action in humans in these studies is consistent with two saturable sites, and supports the hypothesis for transport of insulin to the interstitial space. Saturation may have an impact on minimal model results when high doses of exogenous insulin are given as a bolus, but can be minimized by infusing insulin at a low dose.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567973      PMCID: PMC507043          DOI: 10.1172/JCI118441

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.

Authors:  S Welch; S S Gebhart; R N Bergman; L S Phillips
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

2.  Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin.

Authors:  P A Jansson; J P Fowelin; H P von Schenck; U P Smith; P N Lönnroth
Journal:  Diabetes       Date:  1993-10       Impact factor: 9.461

3.  Receptor-mediated transport of insulin across endothelial cells.

Authors:  G L King; S M Johnson
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

4.  Rapid transport of biologically intact insulin through cultured endothelial cells.

Authors:  K D Dernovsek; R S Bar; B H Ginsberg; M N Lioubin
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

5.  Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose.

Authors:  S E Kahn; L J Klaff; M W Schwartz; J C Beard; R N Bergman; G J Taborsky; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

6.  A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes.

Authors:  D T Finegood; I M Hramiak; J Dupre
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

7.  Effect of heparin on insulin-glucose interactions measured by the minimal model technique: implications for reproducibility using this method.

Authors:  S L Abbate; W Y Fujimoto; J D Brunzell; S E Kahn
Journal:  Metabolism       Date:  1993-03       Impact factor: 8.694

8.  Reproducibility of insulin sensitivity measured by the minimal model method.

Authors:  P Ferrari; Y Alleman; S Shaw; W Riesen; P Weidmann
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

9.  Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph.

Authors:  R A Poulin; G M Steil; D M Moore; M Ader; R N Bergman
Journal:  Diabetes       Date:  1994-02       Impact factor: 9.461

10.  Insulin transport across capillaries is rate limiting for insulin action in dogs.

Authors:  Y J Yang; I D Hope; M Ader; R N Bergman
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more
  23 in total

1.  Ethnic differences in glucose disposal, hepatic insulin sensitivity, and endogenous glucose production among African American and European American women.

Authors:  Amy C Ellis; Jessica A Alvarez; Wesley M Granger; Fernando Ovalle; Barbara A Gower
Journal:  Metabolism       Date:  2011-11-08       Impact factor: 8.694

2.  Stochastic targeted (STAR) glycemic control: design, safety, and performance.

Authors:  Alicia Evans; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Sophie Penning; Fatanah Suhaimi; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

3.  Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion.

Authors:  Susan S Braithwaite; Hemant Godara; Julie Song; Bruce A Cairns; Samuel W Jones; Guillermo E Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass.

Authors:  Jonathan Q Purnell; Geoffrey S Johnson; Abdus S Wahed; Chiara Dalla Man; Francesca Piccinini; Claudio Cobelli; Ronald L Prigeon; Bret H Goodpaster; David E Kelley; Myrlene A Staten; Karen E Foster-Schubert; David E Cummings; David R Flum; Anita P Courcoulas; Peter J Havel; Bruce M Wolfe
Journal:  Diabetologia       Date:  2018-02-10       Impact factor: 10.122

5.  Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia.

Authors:  Marzieh Salehi; Amalia Gastaldelli; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2014-03-10       Impact factor: 5.958

6.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 7.  Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.

Authors:  Tamara S Hannon; Steven E Kahn; Kristina M Utzschneider; Thomas A Buchanan; Kristen J Nadeau; Philip S Zeitler; David A Ehrmann; Silva A Arslanian; Sonia Caprio; Sharon L Edelstein; Peter J Savage; Kieren J Mather
Journal:  Diabetes Obes Metab       Date:  2017-06-22       Impact factor: 6.577

8.  Organ failure and tight glycemic control in the SPRINT study.

Authors:  J Geoffrey Chase; Christopher G Pretty; Leesa Pfeifer; Geoffrey M Shaw; Jean-Charles Preiser; Aaron J Le Compte; Jessica Lin; Darren Hewett; Katherine T Moorhead; Thomas Desaive
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

9.  Overview of glycemic control in critical care: relating performance and clinical results.

Authors:  J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Jason Wong; Jessica Lin; Thomas Lotz; Aaron Lecompte; Timothy Lonergan
Journal:  J Diabetes Sci Technol       Date:  2007-01

10.  Insulin sensitivity, food intake, and cravings with premenstrual syndrome: a pilot study.

Authors:  Kimberly K Trout; Lisa Basel-Brown; Michael R Rickels; Mark H Schutta; Maja Petrova; Ellen W Freeman; Nancy C Tkacs; Karen L Teff
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.